GRAIL’s Galleri® multi-cancer early detection test
The Galleri test is a first-of-its-kind blood test that screens for a fingerprint of many cancers before they become symptomatic, including those with no recommended screening tests today. We provide access to the test to eligible John Hancock Vitality PLUS customers, furthering our commitment to helping people live longer, healthier, better lives.
GRAIL’s Galleri® multi-cancer early detection test
The Galleri test is a first-of-its-kind blood test that screens for a fingerprint of many cancers before they become symptomatic, including those with no recommended screening tests today. We provide access to the test to eligible John Hancock Vitality PLUS customers, furthering our commitment to helping people live longer, healthier, better lives.
Uses a simple blood draw to screen many cancers, the majority of which have no recommended screening tests today.
Results include a prediction to specific tissues and organs to help clinicians focus their diagnostic evaluation.
Available to eligible life insurance customers ages 40+.
Our mission in action
At John Hancock we are committed to helping our customers live longer, healthier, better lives. By providing access to tools and resources like Galleri®, GRAIL’s multi-cancer early detection test, we are driving better health outcomes for our customers. Watch the powerful story of one customer.
Supporting our heroes
In honor of Veteran’s Day, we are sponsoring breakthrough cancer screenings to special operations veterans in collaboration with Home Base as part of our mission to help more people live longer, healthier, better lives.1
According to the American Cancer Society, many military veterans have been exposed to substances, chemicals, and other hazards during their service that can lead to long-term health problems, and in some cases, cancer.2 To help bridge the gap in early cancer detection, for every four Vitality registrations, we will sponsor a Galleri test to special operations veterans. Activate your Vitality account today to help us support our heroes.
Plus, when you activate your Vitality account, you’ll unlock access to your own savings, discounts, rewards and benefits.
Why John Hancock?
More than 160 years of financial strength and stability
So you may trust in our ability to deliver on our promises and be there when our customers need us most.
Over 40 years of long-term care claims-paying experience
With a seasoned team that has successfully supported customers like you for decades, helping ensure reliable and efficient service.
Knowledgeable professionals providing expert guidance
To help you navigate your options and make informed decisions when care is needed.
The John Hancock Vitality program
A program that gives you the opportunity to earn rewards and receive support for making healthy choices, helping you live your best life for years to come.
Looking for more?
About us
For over 160 years, we've been helping our partners build their life insurance businesses and helping their clients protect what matters most.
Explore ensure
You can learn more about other types of life insurance that may align with your goals and needs here.
1Beginning Veteran's Day 2024 and running through at least July 4, 2025, for every four new Vitality registrations, John Hancock will sponsor one Galleri test which will be donated directly to Home Base.
2American Cancer Society: www.cancer.org/cancer/veterans.html
The Galleri test is only available to registered John Hancock Vitality PLUS members who are 40 years of age or older and have completed the Vitality Health Review (VHR) for the current program year. For eligible polices with Face Amounts of $500,000 or greater in life insurance coverage, 100% of the cost of the test will be subsidized. For policies with Face Amounts less than $500,000 in life insurance coverage, 50% of the cost of the test will be subsidized. Test eligibility is also subject to Grail’s clinically informed criteria, as well as additional cancer risk factors for those ages 40-49. Please note: for members with multiple policies, the policy with the highest Face Amount in life insurance coverage will determine the subsidy amount of the Galleri offer. Galleri is a blood test from Grail designed to screen for cancer. The Galleri test does not detect all cancers nor does it diagnose cancer. There may be additional costs for such diagnostic testing. It is intended to be used in addition to, and not replace, other cancer screening tests recommended by a healthcare provider. The sensitivity rate for detecting cancer in the early stages is lower than for later stages. Results should be discussed with a healthcare provider. Test eligibility is subject to certain qualification requirements, including age and certain health risk factors. There is no coordination between John Hancock and any health benefits you may receive from an insurance policy, health plan, or any other wellness programs you may be enrolled in. Galleri is not a test to confirm or rule out genetic or other conditions that may indicate a predisposition to cancer.
Like other medical tests you elect, a decision to take the Galleri test, and the results of the test, may need to be disclosed in an application for insurance coverage, and so could affect your access to future insurance coverage and the price of such coverage. John Hancock does not receive individual test results from GRAIL, nor does it know which customers have requested or taken the test. Your results will have no impact on your current life insurance coverage. For purposes of research, validation of assumptions and evaluation of future health and wellness offerings, John Hancock may receive aggregated and deidentified data from GRAIL from time to time.
The tax treatment of the Galleri test offered in connection with the Vitality Program is uncertain. At this time, John Hancock does not expect that it will be required to report the value of the Galleri test to the IRS as income to the insured. This material does not constitute tax or legal advice and neither John Hancock nor any of its agents, employees or registered representatives are in the business of offering such advice. You should consult your own tax professional.
Access to the Galleri test through the John Hancock Vitality Program is not currently available in all states. The offer of discounted access to the Galleri test is subject to change. John Hancock is not an affiliate of GRAIL. The Galleri test is manufactured and distributed by GRAIL. John Hancock does not provide medical advice, is not involved in the design or manufacture of the Galleri test and is not responsible for the accuracy or performance of the Galleri test.
Vitality is the provider of the John Hancock Vitality Program in connection with policies issued by John Hancock. John Hancock Vitality Program rewards and discounts are available only to the person insured under the eligible life insurance policy, may vary based on the type of insurance policy purchased and the state where the policy was issued, are subject to change and are not guaranteed to remain the same for the life of the policy. To be eligible to earn rewards and discounts by participating in the Vitality program, the insured must register for Vitality and in most instances also complete the Vitality Healthy Review (VHR).
Products or services offered under the Vitality Program are not insurance and are subject to change. There may be additional costs associated with these products or services and there are additional requirements associated with participation in the program. For more information, please contact the company at JohnHancock.com or via telephone at 888-333-2659.
Insurance policies and/or associated riders and features may not be available in all states. Insurance products are issued by: John Hancock Life Insurance Company (U.S.A.), Boston, MA 02116 (not licensed in New York) and John Hancock Life Insurance Company of New York, Valhalla, NY 10595.
MLINY110724719-4
Important Safety InformationThe Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. The Galleri test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. Galleri is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of Galleri is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory / Test Information
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.